C12Y 207/07007
Dna-directed dna polymerase , i.e. dna replicase
Official title: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
C12Y207/07007 (Dna-directed dna polymerase , i.e. dna replicase) appears on 511 US grants and 783 published applications in this corpus.
Search patents in C12Y- Granted patents
- 511
- Published applications
- 783
- Assignees
- 250
- Inventors
- 1,244
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 0 |
| 2003 | 2 | 8 |
| 2004 | 1 | 4 |
| 2005 | 0 | 3 |
| 2006 | 3 | 7 |
| 2007 | 0 | 8 |
| 2008 | 1 | 3 |
| 2009 | 3 | 5 |
| 2010 | 2 | 8 |
| 2011 | 3 | 15 |
| 2012 | 2 | 14 |
| 2013 | 10 | 17 |
| 2014 | 21 | 35 |
| 2015 | 11 | 23 |
| 2016 | 43 | 57 |
| 2017 | 29 | 58 |
| 2018 | 44 | 42 |
| 2019 | 28 | 50 |
| 2020 | 47 | 62 |
| 2021 | 54 | 61 |
| 2022 | 36 | 47 |
| 2023 | 46 | 65 |
| 2024 | 44 | 74 |
| 2025 | 41 | 59 |
| 2026 | 28 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Marine DNA polymerase I15 Sep 2026US 12,735,736 B2Universitetet I Tromso—Norges Arktiske Universitet
- Hot-start antibodies for Taq DNA polymerase variant1 Sep 2026US 12,723,103 B2Watchmaker Genomics, Inc.
- Nucleic acid amplification4 Aug 2026US 12,698,485 B2Life Technologies Corporation
- PUMA1 polymerases and uses thereof28 Jul 2026US 12,692,484 B210x Genomics, Inc.
- Thermostable purified reverse transcriptase and methods of use28 Jul 2026US 12,692,525 B1
- Polymerase variants8 Oct 2026US 2026/0308540 A1Twist Bioscience Corporation
- Methods of engineering cells with mutated genomes using intact large cargo transfer systems8 Oct 2026US 2026/0308568 A1
- Therapeutic circular dna forms1 Oct 2026US 2026/0294957 A1Flagship Pioneering Innovations Vii, LLC
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Compositions and methods for upregulation of reverse transcription and reduction of sequence bias in rna sequencing1 Oct 2026US 2026/0297666 A1
Most cited
By later US patents
- Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use239US 5,176,996 ABaylor College of Medicine · 1993
- Exonuclease-deficient thermostable Pyrococcus furiosus DNA polymerase I190US 5,489,523 AStratagene · 1996
- Enzymes and polymerases for the synthesis of RNA119US 9,512,456 B2ModernaTX, Inc. · 2016
- Nucleic acid ligands that bind to and inhibit DNA polymerases100US 6,020,130 ANeXstar Pharmaceuticals, Inc. · 2000
- Recombinase polymerase amplification96US 8,426,134 B2Alere San Diego, Inc. · 2013